About: pfizer

Health 28-04-2022

Pharma industry improved since before pandemic say patient groups

Since the pandemic, the public image of big pharma companies such as Sanofi, Pfizer, AstraZeneca, and Bayer has improved, according to a survey of 2,150 patient groups worldwide.
Health 14-04-2022

EU defends IP waiver compromise amid pressure on India, South Africa to reject it

A broad international platform of activists, unions and experts has urged India and South Africa to reject the leaked compromise on intellectual property rights on COVID-19 vaccines, which the European Commission considers the ‘most promising path’ to sort out the issue.
Health 09-02-2022

COVID vaccine tracker should be applied to 40 other vaccines, says ECDC

EU countries need to further develop tracking tools to monitor vaccine rates, the director of the EU's infectious disease agency (ECDC) said, amongst talks of centring the role of digital health in preventative care.
Health 28-01-2022

EU watchdog accuses Commission of maladministration over texts to Pfizer CEO

The European Commission's denial of access to text messages between Commission President Ursula von der Leyen and Pfizer CEO Albert Bourla amounts to ‘maladministration’, the EU Ombudsman found.
Coronavirus 27-01-2022

EMA gives green light for EU’s first oral COVID-19 antiviral treatment

The European Medicines Agency (EMA) has recommended the conditional marketing authorisation of Pfizer's new COVID antiviral drug Paxlovid, with official authorisation by the European Commission expected imminently. 
Coronavirus 07-05-2021

US-Germany rift could scupper vaccine patent waiver

A bold US bid to waive patents on much-needed coronavirus vaccines was strongly opposed by Germany on Thursday (6 May), threatening to derail the proposal that requires the consensus of World Trade Organisation members to pass.
Coronavirus 18-02-2021

Commission concerned about COVID vaccines black market

European Commission President Ursula von der Leyen has warned member states that getting supplies of COVID vaccines from illicit trade entails considerable risks for human health.
Health 28-12-2020

Commission: Pfizer to complete supply of 200 million COVID shots by September

The distribution of an initial 200 million doses of the COVID-19 vaccine developed by Pfizer and BioNTech will be completed for the European Union by September, a spokesman for the European Commission said on Monday (28 December). “Distribution of the...